High levels of PD-L1 have been observed in cisplatin-resistant small-cell lung carcinoma cells and enzalutamide-resistant prostate cancer cells36, suggesting the need for further investigation into the effects of rapamycin and other anticancer drugs on resistant cancer cells. The gene discussed is CD274; the disease is Familial prostate cancer.